A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides ...
A common practice for treating patients with gastrointestinal conditions has been revised by the American Gastroenterological Association, it announced Feb. 21. The group has expanded its ...
Researchers may not yet understand the mechanism behind recurrent Clostridium difficile infections, but they may have isolated five risk factors, according to a study published in Infection Control & ...
— Greg Vigna, M.D., J.D. SANTA BARBARA, CA, UNITED STATES, August 3, 2023/EINPresswire.com/ -- “Prolonged IV antibiotics are necessary for the treatment of Grade ...
A recurrence of C. diff is common after an initial episode, with about 20% of people having a recurrence. A recurrence is ...
The first ever pill that mimics the effects of fecal transplants was approved on April 26, 2023, by the U.S. Food and Drug Administration (FDA). The treatment, called Vowst, is created with healthy ...